tetano
Editor, Senior Moderator
J Korean Med Sci
. 2023 Mar 20;38(11):e87.
doi: 10.3346/jkms.2023.38.e87.
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
Yoo-Yeon Kim[SUP] #[/SUP][SUP] 1 [/SUP], Young June Choe[SUP] #[/SUP][SUP] 2 [/SUP], Jia Kim[SUP] 1 [/SUP], Ryu Kyung Kim[SUP] 1 [/SUP], Eun Jung Jang[SUP] 1 [/SUP], Hyeryeon Lee[SUP] 1 [/SUP], Seonju Yi[SUP] 1 [/SUP], Sangwon Lee[SUP] 1 [/SUP], Young-Joon Park[SUP] 3 [/SUP]
Affiliations
Abstract
National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05-0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67-0.84).
Keywords: Booster; COVID-19; Coronavirus; SARS-CoV-2; Vaccine.
. 2023 Mar 20;38(11):e87.
doi: 10.3346/jkms.2023.38.e87.
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
Yoo-Yeon Kim[SUP] #[/SUP][SUP] 1 [/SUP], Young June Choe[SUP] #[/SUP][SUP] 2 [/SUP], Jia Kim[SUP] 1 [/SUP], Ryu Kyung Kim[SUP] 1 [/SUP], Eun Jung Jang[SUP] 1 [/SUP], Hyeryeon Lee[SUP] 1 [/SUP], Seonju Yi[SUP] 1 [/SUP], Sangwon Lee[SUP] 1 [/SUP], Young-Joon Park[SUP] 3 [/SUP]
Affiliations
- PMID: 36942395
- DOI: 10.3346/jkms.2023.38.e87
Abstract
National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05-0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67-0.84).
Keywords: Booster; COVID-19; Coronavirus; SARS-CoV-2; Vaccine.